financetom
Business
financetom
/
Business
/
Madrigal and CSPC Pharmaceutical sign up to $2 billion licensing deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Madrigal and CSPC Pharmaceutical sign up to $2 billion licensing deal
Jul 30, 2025 2:35 AM

July 30 (Reuters) - Madrigal Pharmaceuticals ( MDGL )

said on Wednesday it has entered a global license agreement for

up to $2 billion with CSPC Pharmaceutical ( CHJTF ) to develop

an oral GLP-1 drug for a type of liver disease.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved